8/21/24 08:26 | 8/20/24 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 101 | 0.6700 | 0 | 150 | 6 | 2,781 | D | | | | | | | | | | | | | | |
1/3/24 10:41 | 1/2/24 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -18 | 0.9000 | 0 | -20 | 0 | 12,005 | I | | | | | | | | | | | | | | |
12/20/23 10:31 | 12/15/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -15 | 0.7500 | 0 | -20 | 0 | 12,025 | I | | | | | | | | | | | | | | |
12/19/23 10:59 | 12/18/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8300 | 0 | 10 | 4 | 278 | D | | | | | | | | | | | | | | |
12/18/23 09:38 | 12/15/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.7700 | 0 | 10 | 4 | 268 | D | | | | | | | | | | | | | | |
12/14/23 09:11 | 12/13/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D | | | | | | | | | | | | | | |
12/11/23 08:51 | 12/8/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.6700 | 0 | 10 | 0 | 2,746 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 15 | 0.7700 | 0 | 20 | 1 | 2,601 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 7 | 0.8000 | 0 | 9 | 2 | 428 | D | | | | | | | | | | | | | | |
11/27/23 10:28 | 11/24/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 8 | 0.7600 | 0 | 10 | 0 | 2,581 | D | | | | | | | | | | | | | | |
11/24/23 11:06 | 11/22/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 14 | 0.7100 | 0 | 20 | 1 | 2,571 | D | | | | | | | | | | | | | | |
11/17/23 10:01 | 11/16/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8100 | 0 | 10 | 4 | 258 | D | | | | | | | | | | | | | | |
9/19/23 16:05 | 8/31/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Henshall Mickie | NV | D | | P | 5 | 1.25 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
9/6/23 10:01 | 9/5/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Barnes Phillip | NV | D | | P | 7 | 1.30 | 0 | 5 | 25 | 25 | D | | | | | | | | | | | | | | |
9/1/23 09:41 | 8/31/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | P | 12 | 1.28 | 0 | 10 | 0 | 2,030 | D | | | | | | | | | | | | | | |
8/31/23 09:35 | 8/29/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 25 | 1.25 | 0 | 20 | 6 | 328 | I | | | | | | | | | | | | | | |
8/28/23 10:07 | 8/25/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 1.24 | 0 | 20 | 7 | 308 | D | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kway Jasmine | NV | O | CEO - Si | P | 6 | 1.20 | 0 | 5 | 6 | 87 | I | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 6 | 1.22 | 0 | 5 | 1 | 419 | D | | | | | | | | | | | | | | |
8/24/23 12:00 | 8/24/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Michel Gaetan | NV | O | COO | P | 6 | 1.23 | 0 | 5 | 2 | 213 | D | | | | | | | | | | | | | | |
8/17/23 09:40 | 8/16/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 10 | 1.21 | 0 | 8 | 3 | 254 | D | | | | | | | | | | | | | | |
8/16/23 12:28 | 8/16/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 12 | 1.22 | 0 | 10 | 0 | 2,536 | D | | | | | | | | | | | | | | |
6/6/23 10:14 | 6/2/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 16 | 1.59 | 0 | 10 | 5 | 217 | D | | | | | | | | | | | | | | |
2/23/23 15:54 | 2/22/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 410 | 1.75 | 0 | 234 | 12 | 2,235 | I | | | | | | | | | | | | | | |
12/20/22 10:30 | 12/19/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 11 | 2.27 | 0 | 5 | 3 | 198 | D | | | | | | | | | | | | | | |
12/20/22 10:04 | 12/16/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 72 | 2.22 | 0 | 32 | 14 | 262 | D | | | | | | | | | | | | | | |
12/19/22 09:59 | 12/16/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | P | 116 | 2.10 | 0 | 55 | 3 | 1,993 | D | | | | | | | | | | | | | | |
12/13/22 09:59 | 12/12/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 9 | 2.09 | 0 | 4 | 2 | 193 | D | | | | | | | | | | | | | | |
12/12/22 09:53 | 12/8/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Plummer Nicholas | NV | O | GC - Vol | P | 10 | 2.07 | 0 | 5 | 10 | 51 | D | | | | | | | | | | | | | | |
11/29/22 10:57 | 11/28/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 11 | 2.21 | 0 | 5 | 3 | 188 | D | | | | | | | | | | | | | | |
9/20/22 09:47 | 9/19/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 22 | 1.70 | 0 | 13 | 6 | 222 | I | | | | | | | | | | | | | | |
8/30/22 11:19 | 8/30/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 6 | 1.61 | 0 | 4 | 0 | 2,237 | D | | | | | | | | | | | | | | |
8/30/22 10:14 | 8/26/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 50 | 1.74 | 0 | 29 | 16 | 209 | D | | | | | | | | | | | | | | |
8/24/22 10:52 | 8/23/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 1.60 | 0 | 5 | 3 | 172 | D | | | | | | | | | | | | | | |
8/23/22 11:14 | 8/22/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 1.64 | 0 | 5 | 3 | 167 | D | | | | | | | | | | | | | | |
8/4/22 16:01 | 8/2/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 625 | 2.00 | 0 | 313 | 17 | 2,118 | M | | | | | | | | | | | | | | |
6/17/22 16:05 | 6/16/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | TX | O | CEO - Vo | P | 21 | 2.05 | 0 | 10 | 7 | 162 | D | | | | | | | | | | | | | | |
6/7/22 16:05 | 6/6/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -37 | 2.47 | 0 | -15 | -53 | 13 | D | | | | | | | | | | | | | | |
5/17/22 11:37 | 5/16/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | TX | D | | P | 24 | 2.37 | 0 | 10 | 1 | 1,952 | D | | | | | | | | | | | | | | |
4/13/22 16:01 | 4/11/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -28 | 2.75 | 0 | -10 | -26 | 28 | D | | | | | | | | | | | | | | |
11/18/21 10:39 | 11/16/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | TX | O | CEO-Voli | P | 40 | 4.02 | 0 | 10 | 6 | 167 | D | | | | | | | | | | | | | | |
6/2/21 16:36 | 5/28/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -35 | 3.54 | 0 | -10 | -29 | 25 | D | | | | | | | | | | | | | | |
5/18/21 11:40 | 5/14/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Nguyen Kim | TX | D | | P | 6 | 3.20 | 0 | 2 | 4 | 48 | D | | | | | | | | | | | | | | |
5/18/21 11:37 | 5/14/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | TX | D | | P.m | 503 | 3.35 | 0 | 150 | 8 | 1,941 | D | | | | | | | | | | | | | | |
2/8/21 16:06 | 2/5/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -54 | 5.37 | 0 | -10 | -22 | 35 | D | | | | | | | | | | | | | | |
12/4/20 16:16 | 12/2/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -34 | 3.40 | 0 | -10 | -18 | 45 | D | | | | | | | | | | | | | | |
11/19/20 16:21 | 11/17/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S.m | -17 | 3.37 | 0 | -5 | -8 | 55 | D | | | | | | | | | | | | | | |
9/18/20 17:21 | 9/15/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S.d | -63 | 3.23 | 0 | -20 | -25 | 60 | D | | | | | | | | | | | | | | |
9/18/20 17:21 | 9/18/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | M.d | 62 | 2.47 | 0 | 25 | 72 | 60 | D | | | | | | | | | | | | | | |
9/10/20 10:55 | 9/9/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | TX | D | | S | -209 | 3.21 | 0 | -65 | -3 | 1,862 | D | | | | | | | | | | | | | | |
8/19/20 13:04 | 8/17/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Gaetan Michel | TX | H | Manager- | M.d | 14 | 2.75 | 0 | 5 | | 1 | D | | | | | | | | | | | | | | |
8/14/20 10:47 | 8/12/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | TX | D | | M.d | 83 | 2.75 | 0 | 30 | 2 | 1,435 | D | | | | | | | | | | | | | | |
8/12/20 15:28 | 8/10/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | TX | O | Chief Sc | M.d | 358 | 2.75 | 0 | 130 | 419 | 161 | D | | | | | | | | | | | | | | |
8/6/20 13:58 | 8/4/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | M.d | 69 | 2.75 | 0 | 25 | 85 | 54 | D | | | | | | | | | | | | | | |
7/23/20 16:41 | 7/21/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | TX | DO | P,CEO | M.d | 275 | 2.75 | 0 | 100 | 5 | 2,184 | D | | | | | | | | | | | | | | |
7/23/20 16:32 | 7/21/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | TX | D | | M.d | 165 | 2.75 | 0 | 60 | 3 | 1,927 | D | | | | | | | | | | | | | | |
7/23/20 16:23 | 7/21/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | TX | O | Secretar | M.d | 165 | 2.75 | 0 | 60 | 6 | 1,028 | D | | | | | | | | | | | | | | |
5/22/20 16:27 | 5/22/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | TX | DO | P,CEO | P | 11 | 2.75 | 0 | 4 | 0 | 2,168 | D | | | | | | | | | | | | | | |
12/6/19 10:22 | 12/5/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | TX | DO | P,CEO | P | 5 | 4.24 | 0 | 1 | 0 | 2,164 | D | | | | | | | | | | | | | | |
10/18/19 16:28 | 10/1/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | P | 285 | 5.69 | 0 | 50 | 0 | 12,045 | I | | | | | | | | | | | | | | |
9/30/19 16:13 | 9/26/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -279 | 6.03 | 0 | -46 | 0 | 11,995 | I | | | | | | | | | | | | | | |
8/28/19 12:09 | 8/27/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | TX | D | | P | 38 | 3.75 | 0 | 10 | 1 | 1,917 | D | | | | | | | | | | | | | | |
8/16/19 11:21 | 8/15/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | TX | D | | P | 197 | 3.94 | 0 | 50 | 3 | 1,907 | D | | | | | | | | | | | | | | |
6/13/19 10:47 | 6/11/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | U0 | D | | P | 246 | 3.11 | 0 | 79 | 4 | 1,857 | D | | | | | | | | | | | | | | |
6/12/19 12:43 | 6/10/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | U0 | D | | P | 214 | 3.02 | 0 | 71 | 4 | 1,778 | D | | | | | | | | | | | | | | |
8/17/18 10:42 | 8/16/18 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | U0 | O | Secretar | P | 10 | 1.91 | 0 | 5 | 0 | 1,018 | D | | | | | | | | | | | | | | |
8/17/18 10:39 | 8/16/18 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DO | P,CEO | P | 12 | 1.91 | 0 | 7 | 0 | 2,163 | D | | | | | | | | | | | | | | |
9/19/17 16:28 | 9/19/17 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vanston David Cecil | U0 | O | CFO | P | 8 | 2.84 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
8/17/17 16:11 | 8/16/17 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | U0 | O | Secretar | P | 10 | 2.77 | 0 | 4 | 0 | 1,013 | I | | | | | | | | | | | | | | |
8/17/17 16:08 | 8/16/17 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DO | P,CEO | P | 10 | 2.77 | 0 | 4 | 0 | 2,156 | I | | | | | | | | | | | | | | |
11/28/16 16:06 | 11/25/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | U0 | D | | M.d | 15 | 3.00 | 0 | 5 | 0 | 1,293 | D | 15 | 10 | 34 | 18 | -8 | 4 | 7 | -1 | -2 | -2 | -4 | 0 | | |
11/23/16 14:55 | 11/22/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Colman Alan | U0 | D | | M.d | 15 | 3.00 | 0 | 5 | 3 | 156 | D | 18 | 10 | 29 | 21 | -17 | 6 | 1 | 6 | 4 | -5 | -10 | 0 | | |
11/21/16 16:28 | 11/18/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | U0 | O | Secretar | M.d | 30 | 3.00 | 0 | 10 | | 5 | D | 25 | 7 | 29 | 25 | -12 | 1 | 2 | 8 | -3 | -1 | -7 | -1 | | |
11/21/16 16:24 | 11/18/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | M.d | 15 | 3.00 | 0 | 5 | 0 | 1,230 | D | 25 | 7 | 29 | 25 | -12 | 1 | 2 | 8 | -3 | -1 | -7 | -1 | | |
11/21/16 16:20 | 11/18/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | U0 | O | Chief Sc | M.d | 60 | 3.00 | 0 | 20 | 110 | 38 | I | 25 | 7 | 29 | 25 | -12 | 1 | 2 | 8 | -3 | -1 | -7 | -1 | | |
11/21/16 16:14 | 11/18/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DO | P,CEO | M.d | 60 | 3.00 | 0 | 20 | 2 | 1,115 | D | 25 | 7 | 29 | 25 | -12 | 1 | 2 | 8 | -3 | -1 | -7 | -1 | | |
11/14/16 17:52 | 11/11/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Skaff Habib | FL | D | | M.d | 12 | 3.00 | 0 | 4 | 32 | 16 | D | 8 | 5 | 27 | 26 | -15 | -12 | 5 | 1 | -3 | 5 | -2 | 2 | | |
10/6/16 12:31 | 10/5/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kratochvil David Matthew | U0 | O | CFO | P | 50 | 5.00 | 0 | 10 | New | 10 | D | 22 | 7 | 35 | 58 | 35 | 0 | -13 | -8 | 4 | 8 | -20 | 8 | -17 | |
5/27/16 13:45 | 5/25/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | U0 | D | | M.d | 15 | 3.00 | 0 | 5 | 0 | 1,292 | D | 96 | -9 | -18 | -8 | -12 | 2 | -3 | -5 | 0 | 7 | -1 | 12 | 37 | |
5/24/16 17:01 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | M.d | 15 | 3.00 | 0 | 5 | 0 | 1,229 | D | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
5/24/16 16:57 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DO | P,CEO | M.d | 60 | 3.00 | 0 | 20 | 2 | 1,137 | M | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
5/24/16 16:57 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DO | P,CEO | S.d | -12 | 3.54 | 0 | -3 | 0 | 1,137 | M | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
5/24/16 16:50 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Skaff Habib | FL | D | | M.d | 12 | 3.00 | 0 | 4 | 36 | 15 | D | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
5/24/16 16:44 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | U0 | O | Secretar | M.d | 30 | 3.00 | 0 | 10 | | 2 | D | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
5/24/16 16:38 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Colman Alan | U0 | D | | M.d | 15 | 3.00 | 0 | 5 | 3 | 155 | D | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
5/24/16 16:34 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | U0 | O | Chief Sc | M.d | 60 | 3.00 | 0 | 20 | 174 | 32 | I | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
3/31/16 12:23 | 3/29/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Colman Alan | U0 | D | | M.d | 50 | 0.5000 | 0 | 100 | 185 | 154 | D | 41 | -8 | -16 | -13 | 14 | 9 | 7 | 0 | -6 | -6 | -12 | -18 | 48 | 12 |
3/24/16 11:09 | 3/22/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | M.d | 50 | 0.5000 | 0 | 100 | 9 | 1,270 | D | 22 | -7 | -20 | -9 | 5 | 13 | 8 | 10 | -2 | -9 | -10 | -14 | 26 | 4 |
12/18/15 14:40 | 12/9/15 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | U0 | O | Chief Sc | M.d | 151 | 3.01 | 0 | 50 | | 28 | I | 113 | 12 | 15 | -4 | 15 | 10 | 6 | 6 | -5 | -3 | -19 | -21 | -23 | -11 |
5/18/15 19:02 | 5/15/15 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DOT | P,CEO | P | 5 | 3.33 | 0 | 2 | 0 | 1,104 | D | 40 | 71 | -13 | -16 | -15 | -3 | 16 | 0 | 3 | 6 | 18 | -5 | 18 | -2 |
2/13/15 16:35 | 2/11/15 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | P | 188 | 3.75 | 0 | 50 | 4 | 1,170 | D | 61 | 51 | 122 | 0 | 3 | -16 | -17 | 0 | -4 | -3 | 11 | -18 | -19 | -12 |
9/29/14 12:42 | 9/24/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Colman Alan | U0 | D | | P.e | 7 | 2.20 | 0 | 3 | 6 | 54 | D | 3 | 120 | 65 | 170 | 145 | 120 | 61 | -11 | -3 | -10 | -21 | -19 | -7 | 2 |
9/29/14 12:31 | 9/24/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | P.e | 19 | 2.20 | 0 | 9 | 1 | 1,120 | D | 3 | 120 | 65 | 170 | 145 | 120 | 61 | -11 | -3 | -10 | -21 | -19 | -7 | 2 |
9/17/14 16:47 | 9/15/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | U0 | D | | P | 11 | 2.16 | 0 | 5 | 0 | 1,041 | D | -43 | 23 | -25 | 69 | 23 | 22 | 17 | 7 | 23 | 92 | 30 | 39 | 75 | 101 |
9/3/14 17:17 | 9/3/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DOT | CEO,P | S | 0 | 0.00 | 0 | -1,038 | -33 | 2,106 | M | -53 | -1 | -31 | 30 | 13 | 12 | 0 | -3 | 1 | 2 | 110 | 79 | 95 | 72 |
9/3/14 14:21 | 9/3/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | U0 | O | Secretar | S | -50 | 1.80 | 0 | -28 | -3 | 1,004 | I | -53 | -1 | -31 | 30 | 13 | 12 | 0 | -3 | 0 | 1 | 109 | 79 | 95 | 72 |
3/12/14 21:15 | 3/10/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | P.ed | 50 | 1.18 | 0 | 42 | 4 | 1,112 | I | 8 | 30 | 63 | 67 | 44 | 21 | 18 | 0 | 2 | 3 | -14 | -51 | -34 | 24 |
12/4/13 12:52 | 11/25/13 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | P.edm | 281 | 2.05 | 0 | 137 | 15 | 1,069 | D | | -25 | -8 | 10 | 13 | 73 | 18 | 18 | -3 | -11 | 10 | 44 | -31 | 60 |
11/18/13 18:30 | 3/25/13 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | U0 | D | | P.em | 124 | 1.97 | 0 | 63 | 4 | 1,863 | D | | -51 | -23 | -17 | -15 | -15 | -11 | 31 | 12 | 12 | 24 | 58 | 8 | 135 |